BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24364893)

  • 1. Hemodialysis-induced regional left ventricular systolic dysfunction and inflammation: a cross-sectional study.
    Assa S; Hummel YM; Voors AA; Kuipers J; Westerhuis R; Groen H; Bakker SJ; Muller Kobold AC; van Oeveren W; Struck J; de Jong PE; Franssen CF
    Am J Kidney Dis; 2014 Aug; 64(2):265-73. PubMed ID: 24364893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance.
    Assa S; Hummel YM; Voors AA; Kuipers J; Westerhuis R; de Jong PE; Franssen CF
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1615-23. PubMed ID: 22822014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of isolated ultrafiltration and isovolemic dialysis on myocardial perfusion and left ventricular function assessed with
    Assa S; Kuipers J; Ettema E; Gaillard CAJM; Krijnen WP; Hummel YM; Voors AA; van Melle JP; Westerhuis R; Willemsen A; Slart RHJA; Franssen CFM
    Am J Physiol Renal Physiol; 2018 Mar; 314(3):F445-F452. PubMed ID: 29117996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients.
    Oldani S; Finazzi S; Bottazzi B; Garlanda C; Baldassarre E; Valaperta S; Cuccovillo I; Albini M; Child M; Montanelli A; Graziani G; Badalamenti S
    J Nephrol; 2012; 25(1):120-6. PubMed ID: 21725917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients.
    Kaysen GA; Levin NW; Mitch WE; Chapman AL; Kubala L; Eiserich JP
    Blood Purif; 2006; 24(5-6):508-16. PubMed ID: 17077623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women.
    Masiha S; Sundström J; Lind L
    J Hum Hypertens; 2013 Jan; 27(1):13-7. PubMed ID: 22237633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in left ventricular diastolic function during hemodialysis sessions.
    Assa S; Hummel YM; Voors AA; Kuipers J; Groen H; de Jong PE; Westerhuis R; Franssen CF
    Am J Kidney Dis; 2013 Sep; 62(3):549-56. PubMed ID: 23548554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias.
    Burton JO; Korsheed S; Grundy BJ; McIntyre CW
    Ren Fail; 2008; 30(7):701-9. PubMed ID: 18704819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.
    Lee YJ; Song BG; Kim MS; Cho S; Chun WJ; Oh JH; Kim SR
    Clin Nephrol; 2013 Apr; 79(4):253-60. PubMed ID: 23149248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis-induced regional left ventricular systolic dysfunction.
    Nie Y; Zhang Z; Zou J; Liang Y; Cao X; Liu Z; Shen B; Chen X; Ding X
    Hemodial Int; 2016 Oct; 20(4):564-572. PubMed ID: 27312507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate.
    Selby NM; Burton JO; Chesterton LJ; McIntyre CW
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1216-25. PubMed ID: 17699351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients.
    Mallamaci F; Zoccali C; Parlongo S; Tripepi G; Benedetto FA; Cutrupi S; Bonanno G; Fatuzzo P; Rapisarda F; Seminara G; Stancanelli B; Bellanuova I; Cataliotti A; Malatino LS;
    Kidney Int; 2002 Nov; 62(5):1884-90. PubMed ID: 12371993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure and cardiovascular mortality in dialysis patients with left ventricular systolic dysfunction.
    Losito A; Del Vecchio L; Del Rosso G; Malandra R;
    Am J Hypertens; 2014 Mar; 27(3):401-8. PubMed ID: 24108864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
    Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging--the Multi-Ethnic Study of Atherosclerosis (MESA).
    Edvardsen T; Rosen BD; Pan L; Jerosch-Herold M; Lai S; Hundley WG; Sinha S; Kronmal RA; Bluemke DA; Lima JA
    Am Heart J; 2006 Jan; 151(1):109-14. PubMed ID: 16368301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin: a potential link between inflammation and cardiovascular disease in end stage renal disease patients.
    El-Shehaby AM; El-Khatib MM; Battah AA; Roshdy AR
    Scand J Clin Lab Invest; 2010 Oct; 70(6):421-7. PubMed ID: 20645679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients.
    Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A
    Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning).
    Jefferies HJ; Virk B; Schiller B; Moran J; McIntyre CW
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1326-32. PubMed ID: 21597028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.